A thyroid-related endocrine emergency in pregnancy by Delport, E.F
99
Case Report:  A thyroid-related endocrine emergency in pregnancy
2009 Volume 14 No 2JEMDSA
A thyroid-related endocrine emergency in pregnancy
Delport EF, MBChB, MMed(Int)(Pta)
Steve Biko Academic Hospital and
Department of Internal Medicine, Faculty of Health sciences, University of Pretoria
Correspondence to: Dr Eluned Delport, e-mail: eluned.delport@up.ac.za
Keywords: thyroid storm; pregnancy, endocrine emergency
Case description
A 28-year-old woman, who was 32 weeks pregnant, was following 
up at her local antenatal care clinic for a seemingly uncomplicated 
pregnancy. She had her first antenatal visit at 22 weeks. She had 
a background medical history of hyperthyroidism which had been 
diagnosed a few years before but she was not on any treatment at 
presentation. No other significant medical or family history was of 
note on further enquiry.
At a routine clinic visit she mentioned that she was feeling very 
anxious and noted a fine tremor. She also complained of significant 
weight loss, but did not receive any treatment. Two weeks later she 
went to her local hospital after she became very short of breath and 
also noted that her heart was racing. There she became disorientated 
and confused and was transferred to the tertiary hospital two 
days later.
On arrival the patient was awake but slightly disorientated. 
Examination revealed that she was hot and sweaty and had a fine 
tremor. A sinus tachycardia of 134 beats per minute was present, 
the blood pressure was 140/90 mmHg and the body temperature 
was 38.9°C. The patient was dyspnoeic (NYHA III) and the respiratory 
rate was 29 breaths per minute. Cardiac examination revealed the 
tachycardia, normal first and second heart sounds, and the presence 
of a third heart sound. No extremity oedema was present and the 
jugular venous pressure was normal. The respiratory examination 
showed bilateral coarse crepitations with signs of consolidation in 
the right lower lobe as well as features of pulmonary oedema which 
was confirmed with a chest radiograph. On examination of the thyroid 
it appeared slightly enlarged but with no tenderness and normal 
consistency. There were no features of Graves’ ophthalmopathy 
present.
Thyroid function tests revealed an elevated level of free thyroxine 
(42.7 pmol/L) and a decreased level of thyroid stimulating hormone 
(0.04 mIU/L). Anti-thyroglobulin, anti-thyroid peroxidase and 
anti-thyroid receptor antibodies were positive. The NT-proBNP was 
1360 ng/L which was significantly elevated and the C-reactive 
protein was 48.4 mg/L.
On ultrasound the thyroid gland appeared diffusely enlarged with 
no visible nodes or masses. Cardiac echography was normal and 
excluded cardiomyopathy and underlying valvulopathy. This was in 
keeping with high cardiac output failure. Sonography of the fetus 
showed a viable fetus with a heart rate of 137 beats/ minute.
The diagnosis of a thyroid storm was made and the patient was 
admitted to the medical intensive care unit for management. 
She was immediately started on carbimazole 60 mg, propranolol 
40 mg and Lugol’s iodine. Intravenous co-amoxiclavulanic acid was 
started as treatment for a possible hospital-acquired pneumonia. 
Intravenous furosemide was given for the pulmonary oedema. The 
patient unfortunately went into spontaneous labour and a stillborn 
fetus was delivered. The mother was stabilised and discharged from 
hospital 12 days later.
Discussion
Even though thyroid storm is rare, hyperthyroidism in pregnancy is 
not, with reported prevalence rates ranging from 0.1% to 0.4%.1,2 
Graves’ disease is the most common form of hyperthyroidism and 
accounts for 85% of all cases of hyperthyroidism during pregnancy.3 
Graves’ disease usually becomes less active during the late stages 
of pregnancy. This is possibly due to a change in the activity of TSH 
receptor antibodies from stimulatory to blocking.3,4
Maternal hyperthyroidism is associated with an increased risk of 
pre-eclampsia, maternal heart failure, spontaneous abortion or fetal 
loss, preterm delivery, stillbirth and low birth weight.3,5 The risk of 
complications for both the mother and the fetus is related to the 
duration and control of maternal hyperthyroidism. In patients where 
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the thyrotoxicosis is correctly treated and controlled, the prognosis 
is usually excellent, but in those patients who remain hyperthyroid, 
maternal and fetal complications are increased. Thyroid storm is an 
acute, life-threatening manifestation of thyrotoxicosis. Approximately 
1% of pregnant patients with hyperthyroidism will progress to a 
thyroid storm.6 This can be fatal if unrecognised or left untreated. 
Even with aggressive early treatment the mortality of a thyroid storm 
is 20%.7
A thyroid storm is often precipitated by a physiological stressful event 
such as trauma, infection or surgery.8 In pregnancy a few cases of a 
thyroid storm precipitated by pre-eclampsia, labour and Caesarean 
section have been reported.1 A thyroid storm has also been reported 
to be precipitated by discontinuation of antithyroid drugs.7
Patients can present with a wide variety of signs and symptoms. 
The cardiovascular findings on clinical evaluation include the 
presence of tachycardia, supraventricular arrhythmias or cardiac 
failure.6,9 Neuropsychiatric manifestations include irritability, 
agitation, psychosis, tremor, confusion or alteration in mental status. 
Gastrointestinal symptoms such as diarrhoea, nausea and vomiting 
could also be present. The hyper-metabolic state results in increased 
heat production, with features of hyperpyrexia and increased 
perspiration.7
The diagnosis is usually made on the basis of the clinical features 
alone since it is difficult to obtain rapid laboratory or nuclear medicine 
tests confirming hyperthyroidism. Burch and Wartofsky have outlined 
criteria for the diagnosis of a thyroid storm.9 The Burch and Wartofsky 
Score allows for quantifying the probability of and assessing the 
severity of a thyroid storm (see Table I) Our patient achieved a score 
which was highly suggestive of a thyroid storm. Laboratory test are 
also not helpful in making the diagnosis of a thyroid storm, because 
the serum thyroxine and thyroid stimulating hormone levels are the 
same as those of uncomplicated hyperthyroidism.
Management of a thyroid storm during pregnancy requires special 
attention and treatment due to the adverse effects on the pregnancy 
and fetus.10 A thyroid storm is a medical emergency and requires 
early recognition and aggressive treatment. Treatment is aimed 
at the suppression of synthesis and release of thyroid hormones, 
symptomatic control of the hypermetabolic state and full supportive 
management in an intensive care unit.
The antithyroid drugs available are the thionamides propylthiouracil, 
methimazole and carbimazole (which is metabolised to methimazole). 
These are all effective and have all been used during pregnancy.10,11 
Thionamides block thyroid hormone synthesis within one to two 
hours after administration. Propylthiouracil is the drug of choice in 
pregnancy, based on expert consensus recommendation.1,3 It has 
been shown in recent studies that propylthiouracil and methimazole 
cross the placenta equally and result in an equal chance of inducing 
fetal or neonatal hypothyroidism.12 There have, however been 
reports of teratogenic effects associated with the long term use 
of methimazole, mostly aplasia cutis and choanal or oesophageal 
atresia.1,12 If propylthiouracil is not available (as in South Africa), 
treatment with carbimazole is acceptable3 as the potential maternal 
or fetal risks and the complications due to untreated hyperthyroidism 
outweighs the risk of congenital abnormalities occurring due to 
treatment. Carbimazole is given initially as 40 mg three times a day, 
followed by 40 mg daily. This can be decreased to 20 mg daily or 
less once the disease is under control.11 This could be given via a 
nasogastric tube if the patient is unable to take medicine orally.
High concentrations of iodine are given to inhibit release of stored 
thyroid hormone from the thyroid gland. It is usually given as 
potassium iodide, such as Lugol’s solution, 10 drops three times 
daily.13 This should be given at least one hour after thionamide 
administration to prevent stimulation of new thyroid hormone 
synthesis. Beta-blockers are used to inhibit the adrenergic effects of 
excessive thyroid hormone on the cardiovascular system. Propranolol 
is used as initial therapy and is given either intravenously 6 mg (1 to 
2 mg every 5 minutes) followed by 1 to 10 mg every 4 hours, or orally 
20 to 80 mg every 4 to 6 hours.6,11 It can also be administered via 
nasogastric tube. The use of glucocorticosteroids in a thyroid storm 
improves patient outcome. It prevents peripheral conversion of T4 to 
T3 and may have an effect on the underlying autoimmune disease. 
Glucocorticosteroids are also effective in preventing the potential 
development of adrenal insufficiency.11 Dexamethasone 2 mg 
6 hourly or hydrocortisone 100 mg 8 hourly have been used.
If sedation is required, barbiturates are most often used to reduce 
agitation, because it increases the catabolism of thyroid hormone. 
In addition, other supportive measures should be undertaken which 
Table I: Diagnostic criteria for thyroid storm9 
Thermoregulatory dysfunction Cardiovascular dysfunction
Temperature: Points:
< 37.7 ° C      5 Tachycardia: Points:
37.8–38.3° C 10 99–109 5
38.4–38.8° C 15 110–119 10
38.9–39.4° C 20 120–129 15
39.4–39.9° C 25 130–139 20
> 40 ° C 30 > 140 25
Central nervous system effects Congestive cardiac failure
Mild 10 Mild 5
     - Agitation      - Pedal oedema
Moderate 20 Moderate 10
     - Delirium      - Bibasilar rales
     - Psychosis Severe 15
     - Extreme  
       lethargy      - Pulmonary oedema
Severe 30
     - Seizures Atrial fibrillation 10
     - Coma
Gastrointestinal/hepatic dysfunction Suggestive/precipitant history
Moderate 10 Negative 0
     - Diarrhoea Positive 10
     - Nausea / vomiting
     - Abdominal pain
Severe 20
     - Unexplained jaundice
A score of 45 of more is highly suggestive of a thyroid storm; a score of 25 to 44 supports the diagnosis; 
a score of less than 25 makes a thyroid storm unlikely.
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include oxygen, intravenous fluids and correction of electrolyte 
imbalance, and nutritional support.13 Antipyretics, preferably 
paracetamol, should be given to control the temperature. Salicylates 
should be avoided in thyrotoxicosis, because it decreases thyroid 
hormone protein binding, causing an increase in free thyroid hormone 
levels.7,9 Other measures include tepid water sponge bathing and 
using cooling blankets. Close assessment and continuous maternal 
cardiac monitoring in an intensive care setting is required.13
Fetal well-being should be evaluated sonographically and continuous 
cardiotocographic monitoring of the fetus is required after 28 weeks 
of gestation. It is advised to avoid delivery during a thyroid storm, 
unless the fetal condition demands immediate delivery.6 After the 
crisis, patients should be kept in hospital until delivery or until the 
cardiovascular and metabolic functions have normalised. 
Fetal hyperthyroidism occurs in about 1–5% of cases where the 
mother has hyperthyroidism due to Graves’ disease.14,15 This is due 
to transplacental crossing of maternal thyroid receptor antibodies 
with stimulation of the fetal thyroid. This presents with features 
of fetal hyperthyroidism such as tachycardia, intra uterine growth 
retardation, small for gestational age babies, advanced bone age 
and the development of a fetal goitre.14 Cardiac failure and hydrops 
foetalis are features of severe disease.15
Neonatal hyperthyroidism presents with symptoms of irritability, 
tachycardia, poor feeding and failure to thrive. In severe neonatal 
cases respiratory distress, hyperthermia, hypertension, arrhythmias, 
cardiac failure and death may occur. If the mother has been treated 
with antithyroid drugs, the symptoms of neonatal thyrotoxicosis are 
often not evident at birth and clinical signs only occur 5 to 10 days 
later, when the drug level decreases in the neonate’s circulation.3,15
Conclusion
Thyroid storm is a rare and often fatal presentation of hyper-
thyroidism. It contributes to significant risk in pregnant women 
with hyperthyroidism. It can be precipitated by trauma, infection, 
pre-eclampsia, labour, Caesarean section and by discontinuation of 
antithyroid drugs.
Early recognition and aggressive treatment is fundamental in limiting 
the maternal, fetal and neonatal morbidity and mortality associated 
with this condition. Even with aggressive early treatment the mortality 
of a thyroid storm can be as high as 20%.
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